Metraipolis › archive › dc_907bb7b29459

Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges — Europe PMC PMID:41268537

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41268537
DOI
10.3389/fimmu.2025.1712344
License (as archived)
solo-consultazione
Archived
2026-11-08T19:08:59.109Z
SHA-256 of the archived text
58e6acf6357669873bbaf7129c3c9e15a907043080393c180d4bed34138d34d0
Stable URL of this page
https://metraipolis.com/documento/dc_907bb7b29459

How to cite

Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges — Europe PMC PMID:41268537 — Europe PMC (en), https://europepmc.org/article/MED/41268537 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_907bb7b29459 (Metraipolis archive dc_907bb7b29459, sha256 58e6acf6357669873bbaf7129c3c9e15a907043080393c180d4bed34138d34d0)
BibTeX
@misc{dc907bb7b29459,
  title = {Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges — Europe PMC PMID:41268537},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41268537},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_907bb7b29459; sha256 58e6acf6357669873bbaf7129c3c9e15a907043080393c180d4bed34138d34d0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41268537. Agents can read the archived copy with the MCP tool read_document.